Samsung Instinct has been known, unfortunately as something that could trump the iPhone with regards to features. But everyone knows that it couldn’t. Nonetheless, the Samsung Instinct still sport some rocking features, albeit some were borrowed from Apple. It has a pop-op option screens and list of settings. When there’s […]
Daily Archives: December 21, 2018
573 posts
Job title: Senior Medical Director – Healthcare Communications Agency – NYC Company: Meet Recruitment Job description: Meet are excited to be partnered with a growing agency that is a part of one of the most prestigious networks in the… agency as they’ve recently won new business! The position would allow […]
WASHINGTON (Reuters) – The U.S. Senate adjourned just after 8 p.m. on Friday night (0100 GMT on Saturday), bringing an end to congressional business for the day and thereby ensuring a government shutdown. The Senate is set to return from recess at noon on Saturday (1700 GMT on Saturday). The […]
Breaking News Emails Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings. SUBSCRIBE Dec. 22, 2018 / 1:33 AM GMT By Ethan Sacks The stumble that left Supreme Court Justice Ruth Bader Ginsburg with three fractured ribs proved to be good for her […]
A satisfying end to a three-part story that had a couple swings and misses, check out what we thought of Spider-Man’s third DLC.
Reports have linked the Lakers with a potential trade for the New Orleans Pelicans star. Whilst Pelicans head coach Alvin Gentry flat out declared that there is no way he would be traded, rumours have grown about a deal. It is believed that the Lakers would have to deal multiple […]
(Reuters) – Minnesota prosecutors will not charge the billionaire chief executive officer of China’s JD.com Inc, Richard Liu, after he was accused of rape by a University of Minnesota student during a recent U.S. visit, authorities said on Friday. FILE PHOTO: JD.com founder Richard Liu poses during a Reuters interview […]
(Reuters) – Merck KGaA and Pfizer Inc said on Friday they were ending a late-stage study for their drug to treat a form of ovarian cancer in previously untreated patients. The results showed the drug, Bavencio, in combination with, or as a follow-on treatment to, platinum-based chemotherapy could not achieve […]